Patients with chronic spontaneous urticaria experienced relief in itch and hives by day 3 with povorcitinib, according to ...
In today’s Pharma Pulse, the FDA approves Amgen’s Uplizna (inebilizumab-cdon), the first CD19-targeted therapy for gMG with convenient twice-yearly dosing, and much more.
ORLADEYO now first and only targeted oral prophylactic therapy for patients with HAE aged 2 and older – -Oral pellet formulation provides ...
Around 88% of primary care providers managing patients with uncontrolled asthma reported being unfamiliar or only somewhat ...
5don MSN
Switch off your allergies for years without daily pills? Know the treatment backed by WHO and AAAAI
Allergy shots and drops offer a transformative solution for millions. Major health organisations globally endorse this treatment. It goes beyond symptom relief, reprogramming the immune system for ...
Personal narratives on allergy and asthma conditions which contained inaccuracies gained the most traction online.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback